About Stateline Angels
Stateline Angels, established in 2006, is an angel investment group based in Rockford, United States. It primarily focuses on Series A investments in companies in United States. Its portfolio includes 5 firms, spanning the Life Sciences, High Tech sectors. Its most notable investments include companies like NorthStar Medical Radioisotopes, NovaScan and Madison Scientific. Its latest investment was a $10M Series A round in Madison Scientific on Jan 10, 2025, which also saw participation from WARF and Isthmus Project.
To date, 16 investors have co-invested in Stateline Angels's portfolio companies, including prominent names like Builders VC.
Key Metrics
Founded Year
2006
Location
Rockford, United States
Portfolio Companies
Sectors of Investment
Stages of Investment
Series A, Series B & 1 more
Locations of Investment
Stateline Angels' List of All Investments
Stateline Angels has a portfolio of 5 companies. Their most notable investments are in Kiio and NorthStar Medical Radioisotopes.Their portfolio spans across and United States. They have invested in Life Sciences, High Tech, Enterprise Applications and 1 other sectors, across stages such as Series A, Series B and 1 more. Here is the list of all investments by Stateline Angels:Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market. Its patented technologies include innovative non-uranium-based molybdenum-99 production methods, a novel separation chemistry system, and tools for the nuclear medicine market. Products include Non-HEU 99-Molybdenum and RadioGenix intelligent isotope separation system. Claims to be the first domestic producer of 99-Molybdenum and the only supplier of Non-HEU material.
Key facts about NorthStar Medical Radioisotopes
- Founded Year: 2006
- Location: Madison (United States)
- Stage: Series B
- Total Funding till date: $15.1M
- Employee Count: 322 as on Sep 30, 2026
- Investors: Oberland Capital, Hercules Capital and 5 Others
- Latest Funding Round: Conventional Debt, Oct 02, 2026, $*****
- Highlight: Editors' Pick
2. NovaScan
Developer of diagnostic platform technology for cancer detection. The proprietary impedance-based platform technology for the detection of cancers. The company has developed a single impedance parameter that differs markedly between healthy and cancer tissue, called the Cole Relaxation Frequency.
Key facts about NovaScan
- Founded Year: 2001
- Location: Milwaukee (United States)
- Stage: Series B
- Total Funding till date: $11.2M
- Employee Count: 14 as on Aug 31, 2026
- Investors: Gore Range Capital, Green Park & Golf Ventures and 8 Others
- Latest Funding Round: Series B, Apr 28, 2026, $*****
- Highlight: Editors' Pick
Developer of an integrated management solution for hydrocephalus treatment optimization. The company focuses on creating tools and resources to improve patient care. It aims to provide a comprehensive approach to address the complexities of hydrocephalus management. The goal is to support healthcare professionals in delivering effective treatment strategies.
Key facts about Madison Scientific
- Founded Year: 2020
- Location: Chicago (United States)
- Stage: Series A
- Total Funding till date: $10M
- Employee Count: 27 as on Aug 31, 2026
- Investors: WARF, Central Illinois Angels and 7 Others
- Latest Funding Round: Series A, Jan 10, 2025, $*****
- Highlight: Editors' Pick
4. Kiio
Kiio has developed a digital solution that can screen a patient to determine the type of back pain and offer the appropriate exercises to ease the pain. The company claims to offer a library with over 1,800 unique exercises for health care providers to select and customize based on specific patient needs. The platform also provides instantaneous feedback to health care providers about patient adherence, execution, pain or concerns that the patients may have.
Key facts about Kiio
- Founded Year: 2012
- Location: Madison (United States)
- Stage: Deadpooled
- Total Funding till date: $6.79M
- Employee Count: 3 as on Sep 30, 2026
- Investors: Venture Management, NIH and 4 Others
- Latest Funding Round: Seed, Nov 30, 2017, $*****
Key facts about Kayotechnology
- Founded Year: 2011
- Location: Madison (United States)
- Stage: Deadpooled
- Total Funding till date: $4.19M
- Investors: NIH, Phenomenelle Angels Fund and 3 Others
- Latest Funding Round: Series A, Jul 13, 2016, $*****
Stateline Angels' Year-on-Year Investment Trends
Stateline Angels has invested in 5 companies over the last 14 years, with an average of 0 new investment annually in the last 10 years. In 2025, it made 1 investment. Its most recent first time investment was in Madison Scientific.Stateline Angels' Investments by Stage
Stateline Angels has made 2 investments in Series A stage with an average round size of $5.83M, 2 investments in Series B stage with an average round size of $6.6M and 1 investment in Seed stage with an average round size of $1.66M.Stage of entry | No. of Investments |
|---|---|
Series A | 2 |
Series B | 2 |
Seed | 1 |
Note: We have considered here, only first round of investments
Stateline Angels' Investments by Sector
Stateline Angels has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, HealthTech, High Tech and Vertical SaaS. Notably, it has invested in 4 Enterprise (B2B) companies, 4 Tech companies, 2 Consumer (B2C) companies and at least 2 companies focusing on Social impact.Sector | No. of Investments |
|---|---|
Life Sciences | 3 |
Enterprise Applications | 1 |
HealthTech | 1 |
High Tech | 1 |
Vertical SaaS | 1 |
Note: We have considered here, only first round of investments
Stateline Angels' Investments by Geography
Stateline Angels has made most investments in United States (5).Stateline Angels' recent investments
Stateline Angels has not made any investment in 2026 so far.Here are the most recent investments by Stateline Angels:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jan 10, 2025 | United States | Series A | 1248 | [+6] | |
Nov 17, 2021 | United States | Series B | 8826 | [+4] | |
May 07, 2013 | United States | Seed | 9915 | ||
May 07, 2013 | United States | Series A | 5808 | ||
Sep 05, 2012 | United States | Series B | 1773 |
Co-investors of Stateline Angels
Over the past 14 years, 24 investors have co-invested in Stateline Angels's portfolio companies. This includes funds and angels.
- Invested before Stateline Angels: HHS, NIH and 3 others have invested in rounds before Stateline Angels. There are 2 companies where HHS has invested before Stateline Angels and 2 companies where NIH has invested before Stateline Angels.
- Top Co-investors of Stateline Angels: 16 investors entered a company along with Stateline Angels. These include investors like Builders VC (1 company).
- Invested after Stateline Angels: A total of 3 investors have invested in Stateline Angels's portfolio after their investments. Top Investors include Oberland Capital (1 company) and DOE (1 company).
Recent News related to Stateline Angels
•
Pro golfer Andy North among new investors in Kayo Technology Inc.Journal Sentinel•Kiio, NIH, Stateline Angels